Clinical Trial Update: Multi-center, Single Blinded, RCT, Pivotal Study to Evaluate the Efficacy and Safety of DTx to Improve ADHD [NA]

View source ↗

Summary

A multi-center, single-blinded pivotal randomized trial evaluated a digital therapeutic (DTx) for attention-deficit/hyperactivity disorder and has completed. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• DTx

Snippet

Sponsor: EMOTIV | Conditions: ADHD - Attention Deficit Disorder With Hyperactivity, ADHD - Combined Type | NA | Status: COMPLETED